Radioligands Targeting the Purinergic P2X Receptors

Radioligands Targeting the Purinergic P2X Receptors

Purinergic P2X receptors have a wide distribution within the body and modulate a number of physiological processes, being also involved in the development and progression of inflammation-, neuroinflammation-, neurodegeneration-, and cancer-related diseases. Radioligands that can detect specific P2X...

Full description

Saved in:

Bibliographic Details
Main Authors:	Diego Dal Ben, Michela Buccioni, Catia Lambertucci, Beatrice Francucci, Aleksei Smirnov, Andrea Spinaci, Gabriella Marucci, Rosaria Volpini
Format:	Article
Language:	English
Published:	MDPI AG 2025-06-01
Series:	Cells
Subjects:	P2X receptors radioligands radiotracers imaging PET single-photon emission computed tomography (SPECT)
Online Access:	https://www.mdpi.com/2073-4409/14/13/984
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

An Update on DOTA-Peptides PET Imaging and Potential Advancements of Radioligand Therapy in Intracranial Meningiomas
by: Viviana Benfante, et al.
Published: (2025-04-01)

Theranostic Potential of the iPSMA-Bombesin Radioligand in Patients with Metastatic Prostate Cancer: A Pilot Study
by: Sofía González-Rueda, et al.
Published: (2024-10-01)

A<sub>2A</sub> Adenosine Receptor Antagonists and Their Efficacy in Rat Models of Parkinson’s Disease
by: Andrea Spinaci, et al.
Published: (2025-02-01)

Combination of Radioligand Therapy and Immunotherapy: How to Make It Work in Clinic?
by: Jiao R, et al.
Published: (2025-07-01)

Tolerability of PSMA radioligand therapy in metastatic prostate cancer patients with baseline mild to moderate leukopenia
by: Moritz B. Bastian, et al.
Published: (2025-07-01)

Development and evaluation of a single domain antibody targeting folate receptor alpha for radioligand therapy
by: Jonatan Dewulf, et al.
Published: (2024-12-01)

The therapeutic use of 177 Lu-PSMA-617 radioligand therapy in prostate cancer treatment: a review of literature and ongoing trials
by: Alexander Konopnicki, et al.
Published: (2024-12-01)

In SILICO Characterization of Technetium-99M Radiotracers: ADMET Properties and Protein Interaction Profiles
by: V. Trusova, et al.
Published: (2025-06-01)

Initial clinical experience with [177Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial
by: Aaron R. Hansen, et al.
Published: (2025-01-01)

Biomarkers to optimize PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancer
by: Himisha Beltran, et al.
Published: (2025-08-01)

Production of [18F]DPA-714, [18F]fallypride and [18F]LBT-999 using iMiDEV, a fully automated microfluidic platform: towards clinical radiopharmaceutical production
by: Salla Lahdenpohja, et al.
Published: (2024-12-01)

Development of a toxin-selective immunotracer for in vivo detection of Clostridioides difficile infection by immunoPET
by: Mario González-Arjona, et al.
Published: (2025-06-01)

PyTomography: A python library for medical image reconstruction
by: Lucas A. Polson, et al.
Published: (2025-02-01)

Neuroimaging biomarkers: a critical review of their role in neurological disease diagnosis and management
by: Nitu L. Wankhede, et al.
Published: (2025-06-01)

Implantation of an Artificial Intelligence Denoising Algorithm Using SubtlePET™ with Various Radiotracers: 18F-FDG, 68Ga PSMA-11 and 18F-FDOPA, Impact on the Technologist Radiation Doses
by: Jules Zhang-Yin, et al.
Published: (2025-07-01)

Procedure to optimize the solid angle for the colimation of the nai detector used to measure the flow rate in pipelines
by: Raphael Francisco Gomes Santos, et al.
Published: (2021-04-01)

Thai Guideline for Nuclear Medicine Investigations of Neurocognitive Disorders: Nuclear Medicine Society of Thailand, the Neurological Society of Thailand, and Thai Medical Physicist Society Collaboration
by: Tawika Kaewchur, et al.
Published: (2024-11-01)

Antiproliferative Evaluation of Isofuranodiene on Breast and Prostate Cancer Cell Lines
by: Michela Buccioni, et al.
Published: (2014-01-01)

Radiation-induced brain injury in non-human primates: A dual tracer PET study with [11C]MPC-6827 and [11C]PiB
by: Naresh Damuka, et al.
Published: (2025-03-01)

ABILITIES AND EXPERIENCE OF APPLICATION OF NEUROVISUALIZATION FUNCTIONAL METHODS IN EPILEPTOLOGY
by: M. M. Odinak, et al.
Published: (2016-08-01)

The image reconstruction influence in relative measurement in SPECT / PET / CT animal
by: Sarah Soriano, et al.
Published: (2018-01-01)

A proof-of-concept study of personalized dosimetry for targeted radioligand therapy using pre-treatment diagnostic dynamic PET/CT and Monte Carlo simulation
by: Thanh Tai Duong, et al.
Published: (2025-08-01)

99mTc(CO)3-Labeled 1-(3-Nitropyridin-2-yl) Piperazine as Potential Radioligand for 5-HT7 Receptors
by: Sajjad Molavipordanjani
Published: (2024-12-01)

Novel <sup>177</sup>Lu-Labeled [Thz<sup>14</sup>]Bombesin(6–14) Derivatives with Low Pancreas Accumulation for Targeting Gastrin-Releasing Peptide Receptor-Expressing Cancer
by: Lei Wang, et al.
Published: (2025-03-01)

Diagnostic Value of Nuclear Hybrid Imaging in Malignant Struma Ovarii: A Systematic Review of Case Reports
by: Claudiu Peștean, et al.
Published: (2024-11-01)

Recent Breakthroughs in PET-CT Multimodality Imaging: Innovations and Clinical Impact
by: Dildar Hussain, et al.
Published: (2024-11-01)

Development of Carbon‐11 Labeled Pyrimidine Derivatives as Novel Positron Emission Tomography (PET) Agents Enabling Brain Sigma‐1 Receptor Imaging
by: Ping Bai, et al.
Published: (2025-06-01)

XRF-Escape Scintillator Footprints for Nuclear Medicine Imaging and Gamma-Ray Spectrometry
by: Raffaele Scafè, et al.
Published: (2025-02-01)

DETECTION OF MYOCARDIAL VIABILITY IN ISСHAEMIC DAMAGE USING MAGNETIC RESONANCE AND EMISSION TOMOGRAPHY
by: V. Yu. Ussov, et al.
Published: (2013-12-01)

Editorial: Nuclear medicine advances through artificial intelligence and intelligent informatics
by: Lisa M. Duff, et al.
Published: (2025-01-01)

Current Status and Future Perspectives of Nuclear Medicine in Prostate Cancer from Imaging to Therapy: A Comprehensive Review
by: Joohee Lee, et al.
Published: (2025-05-01)

Pharmacoscintigraphy: Advancing Nanotheranostic Development Through Radionuclide Imaging
by: María Jimena Salgueiro, et al.
Published: (2025-04-01)

Adverse events associated with the use of radiopharmaceuticals: A prospective study from a tertiary care institute
by: Kanhaiyalal Agrawal, et al.
Published: (2025-04-01)

A heterodimeric radioligand labeled with gallium-68 targeting fibroblast activation protein
by: Chengde Xie, et al.
Published: (2025-05-01)

Reliability of the thyroid stimulating hormone receptor antibodies level determination in diagnosing and prognosing of immunogenic hyperthyroidism
by: Aleksić Aleksandar Z., et al.
Published: (2009-01-01)

Microplastic Bioaccumulation by Tiger Snail (Babylonia spirata): Application of Nuclear Technique Capability using Polystyrene Labelled with Radiotracer 65Zn
by: Andhi Susetyo, et al.
Published: (2023-03-01)

GALLIUM-67 CITRATE USED AS A TRACER OF ACETONE PRODUCTION ROUTE
by: Carlos Henrique de Mesquita, et al.
Published: (2019-02-01)

NUCLEAR MEDICINE TECHNIQUES FOR IN VIVO ANIMAL IMAGING
by: Y. A. Finogenova, et al.
Published: (2020-07-01)

Different PSMA Radiopharmaceuticals: A Comparative Study of [<sup>18</sup>F]F-PSMA-1007, [<sup>18</sup>F]F-JK-PSMA-7, and [<sup>99m</sup>Tc]Tc-PSMA-I&S in the Skeletal System
by: Zsófia Sára Mikó, et al.
Published: (2024-10-01)

Prediction of Seizure Outcome Using Combinations of Four Noninvasive Presurgical Modalities in Magnetic Resonance Imaging-negative Focal Intractable Epilepsy
by: Rofat ASKORO, et al.
Published: (2025-02-01)